Healthcare software provider NextGen Healthcare on Wednesday said it has agreed to be bought by private equity firm Thoma Bravo for about $1.61 billion.
Under the terms of the deal, NextGen shareholders will get $23.95 per share in cash, representing a 16.5% premium to stock's last close.
Reuters had first reported in August that the company was exploring options, including a potential sale.
Shares of the company were halted in premarket trading. (Reporting by Bhanvi Satija and Christy Santhosh in Bengaluru; Editing by Dhanya Ann Thoppil)
